GLASF
Price
$7.17
Change
-$0.49 (-6.40%)
Updated
Aug 15 closing price
Capitalization
615.71M
LFCR
Price
$7.37
Change
-$0.05 (-0.67%)
Updated
Aug 15 closing price
Capitalization
275.7M
47 days until earnings call
Interact to see
Advertisement

GLASF vs LFCR

Header iconGLASF vs LFCR Comparison
Open Charts GLASF vs LFCRBanner chart's image
Glass House Brands
Price$7.17
Change-$0.49 (-6.40%)
Volume$260.07K
Capitalization615.71M
Lifecore Biomedical
Price$7.37
Change-$0.05 (-0.67%)
Volume$70.88K
Capitalization275.7M
GLASF vs LFCR Comparison Chart in %
Loading...
GLASF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLASF vs. LFCR commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLASF is a Buy and LFCR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (GLASF: $7.17 vs. LFCR: $7.37)
Brand notoriety: GLASF and LFCR are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GLASF: 66% vs. LFCR: 42%
Market capitalization -- GLASF: $615.71M vs. LFCR: $275.7M
GLASF [@Pharmaceuticals: Generic] is valued at $615.71M. LFCR’s [@Pharmaceuticals: Generic] market capitalization is $275.7M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLASF’s FA Score shows that 0 FA rating(s) are green whileLFCR’s FA Score has 1 green FA rating(s).

  • GLASF’s FA Score: 0 green, 5 red.
  • LFCR’s FA Score: 1 green, 4 red.
According to our system of comparison, LFCR is a better buy in the long-term than GLASF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLASF’s TA Score shows that 5 TA indicator(s) are bullish while LFCR’s TA Score has 5 bullish TA indicator(s).

  • GLASF’s TA Score: 5 bullish, 4 bearish.
  • LFCR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, GLASF is a better buy in the short-term than LFCR.

Price Growth

GLASF (@Pharmaceuticals: Generic) experienced а +13.99% price change this week, while LFCR (@Pharmaceuticals: Generic) price change was +1.80% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +4.25%. For the same industry, the average monthly price growth was +10.98%, and the average quarterly price growth was +78.05%.

Reported Earning Dates

LFCR is expected to report earnings on Oct 02, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+4.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLASF($616M) has a higher market cap than LFCR($276M). GLASF has higher P/E ratio than LFCR: GLASF (513.07) vs LFCR (51.23). GLASF YTD gains are higher at: 23.621 vs. LFCR (-0.808). GLASF has higher annual earnings (EBITDA): 46M vs. LFCR (-13.57M). GLASF has more cash in the bank: 34.6M vs. LFCR (5.42M). GLASF has less debt than LFCR: GLASF (76.1M) vs LFCR (130M). GLASF has higher revenues than LFCR: GLASF (216M) vs LFCR (130M).
GLASFLFCRGLASF / LFCR
Capitalization616M276M223%
EBITDA46M-13.57M-339%
Gain YTD23.621-0.808-2,925%
P/E Ratio513.0751.231,001%
Revenue216M130M166%
Total Cash34.6M5.42M639%
Total Debt76.1M130M59%
FUNDAMENTALS RATINGS
GLASF vs LFCR: Fundamental Ratings
GLASF
LFCR
OUTLOOK RATING
1..100
2460
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
93100
PRICE GROWTH RATING
1..100
4049
P/E GROWTH RATING
1..100
1006
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GLASF's Valuation (94) in the null industry is in the same range as LFCR (99) in the Industrial Specialties industry. This means that GLASF’s stock grew similarly to LFCR’s over the last 12 months.

GLASF's Profit vs Risk Rating (100) in the null industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that GLASF’s stock grew similarly to LFCR’s over the last 12 months.

GLASF's SMR Rating (93) in the null industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that GLASF’s stock grew similarly to LFCR’s over the last 12 months.

GLASF's Price Growth Rating (40) in the null industry is in the same range as LFCR (49) in the Industrial Specialties industry. This means that GLASF’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's P/E Growth Rating (6) in the Industrial Specialties industry is significantly better than the same rating for GLASF (100) in the null industry. This means that LFCR’s stock grew significantly faster than GLASF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLASFLFCR
RSI
ODDS (%)
Bearish Trend 1 day ago
74%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
73%
MACD
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 17 days ago
87%
Bearish Trend 1 day ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 3 days ago
85%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
GLASF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LFCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BHSIF0.03N/A
+9.07%
Bayhorse Silver, Inc.
ASGLY6.150.28
+4.77%
AGC Inc.
NXGCF0.580.02
+3.66%
Nexgold Mining Corp
DHLGY48.880.35
+0.72%
Deutsche Post AG
MEIYF12.40N/A
N/A
Mercialys Paris

GLASF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLASF has been loosely correlated with TSNDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if GLASF jumps, then TSNDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLASF
1D Price
Change %
GLASF100%
-6.40%
TSNDF - GLASF
63%
Loosely correlated
+1.10%
GTBIF - GLASF
62%
Loosely correlated
-12.40%
TCNNF - GLASF
60%
Loosely correlated
-7.35%
VRNOF - GLASF
58%
Loosely correlated
-19.33%
CURLF - GLASF
57%
Loosely correlated
-9.48%
More

LFCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LFCR has been loosely correlated with NBIX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LFCR jumps, then NBIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
-0.67%
NBIX - LFCR
36%
Loosely correlated
+1.21%
SHPH - LFCR
31%
Poorly correlated
-5.14%
TLRY - LFCR
27%
Poorly correlated
-12.71%
GLASF - LFCR
26%
Poorly correlated
-6.40%
ALKS - LFCR
26%
Poorly correlated
+2.80%
More